In order to evaluate which step of adult neurogenesis is mainly affected by MS and by OB administration, we analyze the neural stem cells through the expression of GFP under the control of the nestin promoter (nestin-GFP+ cells) and type-2 and type-3 immature newborn neuroblasts expressing the specific marker DCX. The gene discussed is NES; the disease is myeloid sarcoma.